✦ LIBER ✦

The Narrow Margins of the Dutch Drug Policy: A Cost-Benefit Analysis

✍ Scribed by Jan J.M. Van Dijk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Costs and benefits of the MRSA Search an

✍ M. M. L. van Rijen; J. A. J. W. Kluytmans 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 240 KB

Cost-Benefit Analysis and the Developmen

✍ Eduard Dame; Mike Holland 📂 Article 📅 2001 🏛 Springer Netherlands 🌐 English ⚖ 423 KB

Cost–benefit analysis of drug treatment

✍ William S. Cartwright 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

A Cost-Benefit Analysis of the Thailand

✍ Poapongsakorn, Nipon; Charnvitayapong, Kovit; Laovakul, Duangmanee; Suksiriserek 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 115 KB

How can policy makers use available evid

✍ Christine Godfrey; Steve Parrott 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 15 KB 👁 2 views

A Commentary on Dutch Policy on the Mana

✍ Virginia Berridge 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB